Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | Phf5a (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF5A mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | Phf5a (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of PHF5A mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of PHF5A mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | Phf5a (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHF5A mRNA | CTD | PMID:17942748 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Phf5a (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Phf5a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PHF5A mRNA | CTD | PMID:24058054 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PHF5A mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Phf5a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PHF5A mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PHF5A mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Phf5a (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHF5A mRNA | CTD | PMID:17942748 | 2,4,6-trinitrotoluene | affects expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | Trinitrotoluene affects the expression of PHF5A mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of PHF5A mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of PHF5A mRNA | CTD | PMID:30851411 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PHF5A mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PHF5A mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of PHF5A protein | CTD | PMID:34186270 | aflatoxin B1 | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of PHF5A mRNA | CTD | PMID:23630614 | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of PHF5A mRNA | CTD | PMID:19774075 | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of PHF5A protein | CTD | PMID:25419056 | benzo[a]pyrene | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PHF5A mRNA | CTD | PMID:22228805 | benzo[a]pyrene diol epoxide I | increases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PHF5A mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PHF5A protein | CTD | PMID:34186270 | bisphenol A | multiple interactions | EXP | | 6480464 | [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of PHF5A protein | CTD | PMID:31629898 | bisphenol A | affects methylation | ISO | Phf5a (Mus musculus) | 6480464 | bisphenol A affects the methylation of PHF5A promoter | CTD | PMID:27334623 | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of PHF5A mRNA | CTD | PMID:26079696 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of PHF5A mRNA | CTD | PMID:26472689 | chlorpyrifos | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of PHF5A mRNA | CTD | PMID:37019170 | clobetasol | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | Clobetasol results in increased expression of PHF5A mRNA | CTD | PMID:27462272 | crocidolite asbestos | affects expression | EXP | | 6480464 | Asbestos and Crocidolite affects the expression of PHF5A mRNA | CTD | PMID:17331233 | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos and Crocidolite results in increased expression of PHF5A mRNA | CTD | PMID:29523930 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PHF5A mRNA | CTD | PMID:28628672 | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of PHF5A protein | CTD | PMID:25419056 | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PHF5A protein | CTD | PMID:23301498 | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PHF5A mRNA | CTD | PMID:29432896 | fenthion | decreases expression | ISO | Phf5a (Mus musculus) | 6480464 | Fenthion results in decreased expression of PHF5A mRNA | CTD | PMID:34813904 | fipronil | decreases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of PHF5A mRNA | CTD | PMID:34044035 | flavonoids | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of PHF5A mRNA | CTD | PMID:18035473 | flutamide | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of PHF5A mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Phf5a (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF5A mRNA | CTD | PMID:22206623 | folic acid | increases expression | EXP | | 6480464 | Folic Acid results in increased expression of PHF5A mRNA | CTD | PMID:27293554 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of PHF5A protein | CTD | PMID:37730182 | gentamycin | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of PHF5A mRNA | CTD | PMID:22061828 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PHF5A mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of PHF5A protein | CTD | PMID:32959892 | lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of PHF5A mRNA | CTD | PMID:19921347 | nefazodone | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of PHF5A mRNA | CTD | PMID:24136188 | nimesulide | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of PHF5A mRNA | CTD | PMID:24136188 | paracetamol | affects expression | ISO | Phf5a (Mus musculus) | 6480464 | Acetaminophen affects the expression of PHF5A mRNA | CTD | PMID:17562736 | phenol red | multiple interactions | EXP | | 6480464 | [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of PHF5A protein | CTD | PMID:31629898 | picoxystrobin | increases expression | EXP | | 6480464 | picoxystrobin results in increased expression of PHF5A mRNA | CTD | PMID:33512557 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of PHF5A mRNA | CTD | PMID:30851411 | resveratrol | decreases expression | ISO | Phf5a (Mus musculus) | 6480464 | resveratrol results in decreased expression of PHF5A protein | CTD | PMID:25505154 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of PHF5A mRNA | CTD | PMID:23557933 | rotenone | decreases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of PHF5A protein | CTD | PMID:35544339 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of PHF5A mRNA | CTD | PMID:25895662 | tamoxifen | affects expression | ISO | Phf5a (Mus musculus) | 6480464 | Tamoxifen affects the expression of PHF5A mRNA | CTD | PMID:17555576 | tetrachloromethane | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of PHF5A mRNA | CTD | PMID:31919559 | toluene | decreases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | Toluene results in decreased expression of PHF5A mRNA | CTD | PMID:22967744 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of PHF5A mRNA | CTD | PMID:28542535 | trimellitic anhydride | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of PHF5A mRNA | CTD | PMID:19042947 | Triptolide | increases expression | ISO | Phf5a (Rattus norvegicus) | 6480464 | triptolide results in increased expression of PHF5A protein | CTD | PMID:32519852 | triptonide | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | triptonide results in increased expression of PHF5A mRNA | CTD | PMID:33045310 | tungsten | increases expression | ISO | Phf5a (Mus musculus) | 6480464 | Tungsten results in increased expression of PHF5A mRNA | CTD | PMID:30912803 | tunicamycin | decreases expression | EXP | | 6480464 | Tunicamycin results in decreased expression of PHF5A mRNA | CTD | PMID:29453283 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PHF5A mRNA | CTD | PMID:23179753 and PMID:27188386 | |